|
WO2021011630A1
|
|
Assay apparatuses, methods and reagents
|
|
US2021003484A1
|
|
Device and method for determining liquid contact and liquid volume in a liquid dispenser based on sound
|
|
WO2020227016A1
|
|
Kits for detecting one or more target nucleic acid analytes in a sample and methods of making and using the same
|
|
WO2020219495A1
|
|
Assay apparatuses, methods and reagents including devices and methods for reducing crosstalk between ccd measurements
|
|
WO2020180645A1
|
|
Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same
|
|
US2020141950A1
|
|
Diagnostic methods for inflammatory disorders
|
|
WO2020142313A1
|
|
Compositions and methods for carrying out assay measurements
|
|
WO2020086751A1
|
|
Methods for isolating surface marker displaying agents
|
|
WO2019222708A2
|
|
Methods for isolating surface marker displaying agents
|
|
WO2019222445A1
|
|
High throughput system for performing assays using electrochemiluminesence including a consumable shaking apparatus
|
|
US2021048431A1
|
|
Genetic marker and/or biomarkers for traumatic brain injury, and ultrasensitive assays for biomarkers of traumatic brain injury
|
|
WO2019165304A1
|
|
Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule
|
|
US2019291103A1
|
|
Methods for conducting multiplexed assays
|
|
US2018188269A1
|
|
Diagnostic methods for liver disorders
|
|
US2017234892A1
|
|
Antibody array for measuring a panel of amyloids
|
|
CA3031446A1
|
|
Integrated consumable data management system & platform
|
|
WO2017015636A1
|
|
Integrated consumable data management system & platform
|
|
US2016238536A1
|
|
Replaceable detection module
|
|
CN108136350A
|
|
Including consumables shake equipment for the high throughput system that is measured using electrochemical luminescence
|
|
AU2016201009A1
|
|
Assay plates reader systems and methods for luminescence test measurements
|
